I don't think "strictness" is quite the right axis when we're talking about regulatory capture. It can simultaneously be true that FDA requirements lock out almost everyone who'd like to enter the market *and* that those requirements don't effectively filter new drugs
-
-
This Tweet is unavailable.
-
- Show replies
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.